Detalhe da pesquisa
1.
Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier.
J Formos Med Assoc
; 121(1 Pt 2): 319-328, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006465
2.
Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety.
J Formos Med Assoc
; 121(12): 2430-2437, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153210
3.
Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC.
Front Oncol
; 12: 1022994, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36761415
4.
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study.
Mayo Clin Proc
; 94(7): 1147-1157, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272565